| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$22,312 |
REA Group H1 FY26 Financial Information Released
|
6 Feb 2026 8:20AM |
$182.390 |
$168.880 |
fallen by
7.41%
|
|
REA - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue increased to AUD 916 million, up 5% from the previous year.
- Australian revenue rose by 8% to AUD 872 million.
- International revenue decreased by 31% due to strategic divestments.
- Operating expenses grew by 3%, while EBITDA increased by 6%.
- Net profit attributable to parent shareholders improved by 9%.
- An interim dividend of AUD 1.24 per share was declared, a 13% increase.
- REA Group maintains a strong balance sheet with no external debt.
- The company announced a share buy-back program up to AUD 200 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PWR Holdings Limited (PWH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,005 |
Appointment of Chief Financial Officer
|
6 Feb 2026 8:20AM |
$8.970 |
$9.990 |
risen by
11.37%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$22 |
GSS Appoints Anne Lockwood as Interim Managing Director
|
6 Feb 2026 8:20AM |
$0.145 |
$0.095 |
fallen by
34.48%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Anne Lockwood appointed as Interim Managing Director of Genetic Signatures Limited.
- Anne Lockwood previously served as Non-Executive Director at Genetic Signatures.
- Anne Lockwood has over 30 years of experience in finance, risk management, and audit.
- Lockwood will collaborate with CEO Maria Halasz to execute the company’s strategy.
- Anne Lockwood will serve as Interim Managing Director for six months.
- The Board will review the company’s management arrangements after six months.
- The appointment of a permanent CFO is deferred during Lockwood's interim period.
- The management restructure aims to reduce personnel costs and support shareholder value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$22,312 |
Dividend/Distribution - REA
|
6 Feb 2026 8:20AM |
$182.390 |
$168.880 |
fallen by
7.41%
|
|
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$582 |
Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC
|
6 Feb 2026 8:19AM |
$0.380 |
$0.395 |
risen by
3.95%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Immutep achieves 50% enrolment in TACTI-004 Phase III trial.
- Trial evaluates eftilagimod alfa (efti) with KEYTRUDA® and chemotherapy.
- Enrolment target is 756 patients globally for advanced/metastatic 1L NSCLC.
- Combination therapy aims to improve response across all PD-L1 expression levels.
- Futility analysis expected in Q1 2026, full enrolment by Q3 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$22,312 |
Appendix 4D and Interim Financial Report H1 FY26
|
6 Feb 2026 8:19AM |
$182.390 |
$168.880 |
fallen by
7.41%
|
|
REA - Price-sensitive ASX Announcement
Full Release
Key Points
- REA Group Ltd reported a total revenue of $1,043.4 million for the half-year ended 31 December 2025.
- Operating income increased to $915.8 million, with total expenses from franchisee commissions amounting to $145.0 million.
- EBITDA from core operations amounted to $552.1 million after accounting for impairment and revaluation expenses.
- Profit before income tax was $488.0 million, and profit after income tax was $332.8 million.
- Total comprehensive income for the half-year was $325.8 million, with a significant portion attributed to foreign exchange losses.
- The company's net assets as of 31 December 2025 were $2,094.7 million, up from $1,951.2 million as of 30 June 2025.
- REA Group Ltd maintained a strong cash position with cash and cash equivalents of $478.4 million.
- The Group held a syndicated debt facility of $200 million, which remained undrawn as of 31 December 2025.
- An interim dividend of $1.24 per share fully franked was declared, reflecting a 13% increase.
- The financial report includes the company's revenue growth in the Property & Online Advertising and Financial Services sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advance Metals Limited (AVM) ORDINARY FULLY PAID |
Materials |
$49 |
Historic Core Sampling Highlights Yoquivo Resource Potential
|
6 Feb 2026 8:19AM |
$0.125 |
$0.105 |
fallen by
16%
|
|
AVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Advance Metals conducted a core sampling program at Yoquivo.
- 5,000 meters of historic core were tested; 519 meters showed elevated values.
- High-grade intervals exceeding 100g/t AgEq were found in 13 holes.
- Broad mineralization intersections suggest potential for bulk tonnage mining.
- Evaluation of different cutoff grade scenarios for JORC resource upgrade is planned.
- Exploration results indicate significant potential for resource expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,437 |
Update - Notification of buy-back - KAR
|
6 Feb 2026 8:19AM |
$1.665 |
$2.000 |
risen by
20.12%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,725 |
Update - Notification of buy-back - MGH
|
6 Feb 2026 8:19AM |
$4.110 |
$4.780 |
risen by
16.30%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$33 |
December 2025 Quarter Financial Statement and MD&A
|
6 Feb 2026 8:19AM |
$0.305 |
$0.300 |
fallen by
1.64%
|
|
RAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Total comprehensive loss for the quarter was $1,108,051.
- Management fees and exploration expenditures were significant costs.
- Continuation of the metallurgical study for the Tiros Project.
- Engaged in private placements raising $1,882,823.
- Net change in cash of $173,929 for the period.
- Listed on ASX, TSX.V, and OTCQB under different symbols.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marimaca Copper Corp. (MC2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$1,077 |
Marimaca Copper Presentation - February 2026
|
6 Feb 2026 8:18AM |
$12.490 |
$9.020 |
fallen by
27.78%
|
|
| Future Metals NL (FME) ORDINARY FULLY PAID |
Materials |
$20 |
Presentation - Commodity price window is open for Panton
|
6 Feb 2026 8:18AM |
$0.028 |
$0.021 |
fallen by
25%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,424 |
Update - Notification of buy-back - DNL
|
6 Feb 2026 8:18AM |
$3.260 |
$3.060 |
fallen by
6.13%
|
|
| Ballymore Resources Limited (BMR) ORDINARY FULLY PAID |
Materials |
$45 |
Initial Torpys step-out drilling confirms scale potential
|
6 Feb 2026 8:18AM |
$0.320 |
$0.215 |
fallen by
32.81%
|
|
BMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Ballymore Resources Limited (ASX:BMR) conducted initial step-out drilling at the Torpy’s site.
- Drill hole BTPRC007 at Little Torpy's confirmed significant base metal intersections, including 30m at 58.4 g/t Ag, 4.29% Pb, and 3.70% Zn from 22m.
- The results indicate the potential for multiple high-grade silver-lead-zinc ore lenses in the area.
- The drilling program aims to define the scale potential of the Torpy’s mineral system.
- Preparations for follow-up drilling are underway, pending weather conditions.
- Additional targets have been identified in similar structural settings across the greater Torpy’s area.
- The results are consistent with Ballymore’s model of significant mineralisation extending beyond the main Torpy’s workings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Northern Star Resources Ltd (NST) ORDINARY FULLY PAID |
Materials |
$36,212 |
MGX: Completion of CTPJV acquisition
|
6 Feb 2026 8:18AM |
$27.240 |
$25.310 |
fallen by
7.09%
|
|
| Tanami Gold NL (TAM) ORDINARY FULLY PAID |
Materials |
$135 |
MGX: Completion of CTPJV acquisition
|
6 Feb 2026 8:18AM |
$0.091 |
$0.115 |
risen by
26.37%
|
|
| MGX Resources Limited (MGX) ORDINARY FULLY PAID |
Materials |
$496 |
Completion of CTPJV acquisition
|
6 Feb 2026 8:18AM |
$0.440 |
$0.420 |
fallen by
4.55%
|
|
MGX - Price-sensitive ASX Announcement
Full Release
Key Points
- MGX acquires 50% interest in CTPJV from Northern Star Resources.
- The acquisition cost was $50 million plus $5.8 million in bank guarantees.
- CTPJV has an estimated 31.0 Mt grading 2.8 g/t gold for 2.8 Moz.
- Includes 3,600 square kilometers of exploration tenure.
- MGX intends to develop and accelerate activities with partners.
- Project offers potential for a long-life gold business under positive market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$258 |
Change in substantial holding
|
6 Feb 2026 8:18AM |
$0.350 |
$0.300 |
fallen by
14.29%
|
|
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$190 |
Ceasing to be a substantial holder
|
6 Feb 2026 8:18AM |
$2.700 |
$2.340 |
fallen by
13.33%
|
|
| Canadian Phosphate Limited (CP8) ORDINARY FULLY PAID |
Materials |
$28 |
Appointment of Strategic Advisory Team
|
6 Feb 2026 8:18AM |
$0.081 |
$0.080 |
fallen by
1.23%
|
|
| E79 Gold Mines Limited (E79) ORDINARY FULLY PAID |
Materials |
$12 |
Becoming a substantial holder - E79 Gold (escrow)
|
6 Feb 2026 8:17AM |
$0.029 |
$0.035 |
risen by
20.69%
|
|
| Perseus Mining Limited (PRU) ORDINARY FULLY PAID |
Materials |
$7,283 |
Update - Notification of buy-back - PRU
|
6 Feb 2026 8:17AM |
$5.510 |
$5.390 |
fallen by
2.18%
|
|
| Perseus Mining Limited (PRU) ORDINARY FULLY PAID |
Materials |
$7,283 |
Ceasing to be a substantial holder
|
6 Feb 2026 8:17AM |
$5.510 |
$5.390 |
fallen by
2.18%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,948 |
Ceasing to be a substantial holder
|
6 Feb 2026 8:17AM |
$20.470 |
$18.940 |
fallen by
7.47%
|
|
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$50,967 |
144 Report of proposed sale of securities
|
6 Feb 2026 8:17AM |
$37.460 |
$34.990 |
fallen by
6.59%
|
|